Estimation of residue depletion of cyadox and its marker residue in edible tissues of pigs using physiologically based pharmacokinetic modelling

References

• [AVMA] American Veterinary Medical Association. 2001. Panel on Euthanasia 2000 Report of the AVMA panel on euthanasia. J Am Vet Med A. 218:669–696.
   Web of Science ®Google Scholar
• Badham HJ, Winn LM. 2010. In utero exposure to benzene disrupts fetal hematopoietic progenitor cell growth via reactive oxygen species. Toxicol Sci. 113:207–215.
   PubMed Web of Science ®Google Scholar
• Barton HA, Chiu WA, Setzer RW, Andersen ME, Bailer AJ, Bois FY, Dewoskin RS, Hays S, Johanson G, Jones N. 2007. Characterising uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. Toxicol Sci. 99:395–402.
   PubMed Web of Science ®Google Scholar
• Baynes RE, Riviere JE. 2014. Strategies for reducing drug and chemical residues in food animals: international approaches to residue avoidance, management, and testing. 1st ed. Hoboken (NJ): Wiley & Sons.
   Google Scholar
• Buur JL, Baynes R, Smith G, Riviere JE. 2006. Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrob Agents Chemother. 50:2344–2351.
   PubMed Web of Science ®Google Scholar
• Buur JL, Baynes RE, Craigmill AL, Riviere JE. 2005. Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. Am J Vet Res. 66:1686–1693.
   PubMed Web of Science ®Google Scholar
• Buur JL, Baynes RE, Riviere JE. 2008. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model. Regul Toxicol Pharmacol. 51:324–331.
   PubMed Web of Science ®Google Scholar
• Cheng XG, Ju WZ, Dai GL, Ma S, Tan HS. 2013. Plasma protein binding rate of procyanidin B2, epicatechin by equilibrium dialysis method in human plasma. Chinese Pharmacol Bullet. 29:1465–1467.
   Google Scholar
• Chiesa OA, Von Bredow J, Nochetto C, Smith M, Heller D, Moulton K, Thomas MH. 2006. Use of tissue-fluid correlations to estimate gentamicin residues in kidney tissue of Holstein steers. J Vet Pharmacol Ther. 29:99–106.
   PubMed Web of Science ®Google Scholar
• Chiesa OA, Von Bredow J, Smith M, Heller D, Condon R, Thomas MH. 2006. Bovine kidney tissue/biological fluid correlation for penicillin. J Vet Pharmacol Ther. 29:299–306.
   PubMed Web of Science ®Google Scholar
• Corley RA, Bartels MJ, Carney EW, Weitz KK, Soelberg JJ, Gies RA, Thrall KD. 2005 Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic Acid, in rats and humans. Toxicol Sci. 85:476–490.
   PubMed Web of Science ®Google Scholar
• Cortright KA, Wetzlich SE, Craigmill AL. 2009. A PBPK model for midazolam in four avian species. J Vet Pharmacol Ther. 32:552–565.
   PubMed Web of Science ®Google Scholar
• Covington TR, Gentry PR, Van Landingham CB, Andersen ME, Kester JE, Clewell HJ. 2007. The use of Markov chain Monte Carlo uncertainty analysis to support a public health goal for perchloroethylene. Regul Toxicol Pharmacol. 47:1–18.
   PubMed Web of Science ®Google Scholar
• Craigmill AL. 2003. A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. J Vet Pharmacol Ther. 26:55–63.
   PubMed Web of Science ®Google Scholar
• Ding MX, Wang YL, Zhu HL, Yuan ZH. 2006. Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets. J Anim Sci. 84:2367–2373.
   PubMed Web of Science ®Google Scholar
• Ding MX, Yuan ZH, Wang YL, Zhu HL, Fan SX. 2006. Olaquindox and cyadox stimulate growth and decrease intestinal mucosal immunity of piglets orally inoculated with Escherichia coli. J Anim Physiol Anim Nutr. 90:238–243.
   PubMed Web of Science ®Google Scholar
• Hao H, Guo W, Iqbal Z, Cheng G, Wang X, Dai M, Huang L, Wang Y, Peng D, Liu Z, et al. 2013. Impact of cyadox on human colonic microflora in chemostat models. Regul Toxicol Pharmacol. 67:335–343.
   PubMed Web of Science ®Google Scholar
• He QH, Fang GJ, Wang YL, Wei ZC, Wang DJ, Zhou SQ, Sx F, Yuan ZH. 2006. Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin. Photodermatol Photo. 22:100–104.
   PubMed Web of Science ®Google Scholar
• Huang C, Lei H, Zhao X, Tang H, Wang Y. 2013. Metabolic influence of acute cyadox exposure on Kunming mice. J Proteome Res. 12:537–545.
   PubMed Web of Science ®Google Scholar
• Huang LL, Xu N, Sechenchogt H, Pan YH, Chen DM, Tao YF, Liu ZL, Yuan ZH. 2015. Metabolic disposition and elimination of cyadox in pigs, chickens, carp and rats. J Agr Food Chem. 63:5557–5569.
   PubMed Web of Science ®Google Scholar
• Huang X-J, Zhang -H-H, Wang X, Huang -L-L, Zhang L-Y, Yan C-X, Liu Y, Yuan Z-H. 2010. ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro. Chem Biol Interact. 185:227–234.
   PubMed Web of Science ®Google Scholar
• Krenitisky TA, Tuttle JV, Cattau EL, Wang P. 1974. A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp Biochem Physiol. 49B:687–703.
   Google Scholar
• Leavens TL, Tell LA, Clothier KA, Griffith RW, Baynes RE, Riviere JE. 2012. Development of a physiologically based pharmacokinetic model to predict tulathromycin distribution in goats. J Vet Pharmacol Ther. 35:121–131.
   PubMed Web of Science ®Google Scholar
• Leavens TL, Tell LA, Kissell LW, Smith GW, Smith DJ, Wagner SA, Shelver WL, Wu H, Baynes RE, Riviere JE. 2014. Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus). Food Addit Contam A. 31:1506–1521.
   PubMed Web of Science ®Google Scholar
• Li M, Gehring R, Lin Z, Riviere J. 2015. A framework for meta-analysis of veterinary drug pharmacokinetic data using mixed effect modeling. J Pharm Sci. 104:1230–1239.
   PubMed Web of Science ®Google Scholar
• Li YF, Zhao N, Zeng ZL, Gu XY, Fang BH, Yang F, Zhang BX, Ding HZ. 2013. Tissue deposition and residue depletion of cyadox and its three major metabolites in pigs after oral administration. J Agric Food Chem. 61:9510–9515.
   PubMed Web of Science ®Google Scholar
• Lin Z, Fisher JW, Ross MK, Filipov NM. 2011. A physiologically based pharmacokinetic model for atrazine and its main metabolites in the adult male C57BL/6 mouse. Toxicol Appl Pharmacol. 251:16–31.
   PubMed Web of Science ®Google Scholar
• Lin Z, Fisher JW, Wang R, Ross MK, Filipov NM. 2013. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling. Toxicol Appl Pharmacol. 273:140–158.
   PubMed Web of Science ®Google Scholar
• Lin Z, Li M, Gehring R, Riviere JE. 2015. Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans. J Pharm Sci. 104:233–243.
   PubMed Web of Science ®Google Scholar
• Liu ZY, Huang LL, Dai MH, Chen DM, Tao YF, Wang YL, Yuan ZH. 2009. Metabolism of cyadox in rat, chickens and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 23:2026–2034.
   Google Scholar
• Liu Y, Huang LL, Wang YL, Yang B, Ishan A, Fang K, Peng DP, Liu ZL, Dai MH, Yuan ZH. 2010. Tissue depletion and concentration correlations between edible tissues and biological fluids of 3-amino-2-oxazolidinone in pigs fed with a furazolidone medicated feed. J Agric Food Chem. 58:6774–6779.
   PubMed Web of Science ®Google Scholar
• Mercer HD, Baggot JD, Sams RA. 1977. Application of pharmacokinetic methods to the drug residue profile. J Toxicol Environ Health. 2:787–801.
   PubMed Web of Science ®Google Scholar
• Mirfazaelian A, Kim KB, Anand SS, Kim HJ, Tornero-Velez R, Bruckner JV, Fisher JW. 2006. Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat. Toxicol Sci. 93:432–442.
   PubMed Web of Science ®Google Scholar
• Mu P, Zheng M, Xu M, Zheng Y, Tang X, Wang Y, Wu K, Chen Q, Wang L, Deng Y. 2014. N-oxide reduction of quinoxaline-1,4-dioxides catalyzed by porcine aldehyde oxidase SsAOX1. Drug Metab Dispos. 42:511–519.
   PubMed Web of Science ®Google Scholar
• Parks DA, Granger DN. 1986. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand. 548:87–99.
   Google Scholar
• Qiu YM. 2012. Residue depletion of cyadox in pigs, chickens and carp [master dissertation]. Wuhan: Huazhong Agricultural University.
   Google Scholar
• Qiu YS, Fan SX, Liu DC, Huang LL, Yin JY. 2002. Determination of Cyadox and Bisdesoxycyadox in plasma and edible tissues using high-performance liquid chromatography. Chinese J Vet Sci. 23:363–365.
   Google Scholar
• Riviere JE. 2011. Comparative Pharmacokinetics: Principles, Techniques, and Applications. 2nd ed. Ames, IA: Wiley-Blackwell.
   Google Scholar
• Saksela M, Lapatto R, Raivio KO. 1998. Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues. Biol Neonate. 74:274–280.
   PubMedGoogle Scholar
• Sarnesto A, Linder N, Raivio KO. 1996. Organ distribution and molecular forms of human xanthine dehydrogenase, xanthine oxidase protein. Lab Invest. 74:48–56.
   PubMed Web of Science ®Google Scholar
• Tranquilli WJ, Parks CM, Thurmon JC, Benson GJ, Koritz GD, Manohar M, Theodorakis MC. 1982. Organ blood flow and distribution of cardiac output in nonanesthetized swine. Am J Vet Res. 43:895–897.
   PubMed Web of Science ®Google Scholar
• Upton RN. 2008. Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling. Pharmacol Toxicol Methods. 58:198–205.
   PubMedGoogle Scholar
• Wang X, Fang G-J, Wang Y-L, Ihsan A, Huang -L-L, Zhou W, Liu Z-L, Yuan Z-H. 2011. Two generation reproduction and teratogenicity studies of feeding cyadox in Wistar rats. Food Chem Toxicol. 49:1068–1079.
   PubMed Web of Science ®Google Scholar
• Wang X, He Q-H, Wang Y-L, Ihsan A, Huang -L-L, Zhou W, Su S-J, Liu Z-L, Yuan Z-H. 2011. A chronic toxicity study of cyadox in Wistar rats. Regul Toxicol Pharm. 59:324–333.
   PubMed Web of Science ®Google Scholar
• Wang YL, Yuan ZH, Zhu HL, Ding MX, Fan SX. 2005. Effect of cyadox on growth and nutrient digestibility in weanling pigs. S Afr J Anim Sci. 35:117–125.
   Web of Science ®Google Scholar
• [WHO] World Health Organisation. 2010. Characterization and application of physiologically based pharmaco-kinetic models in risk assessment. Geneva: World Health Organization; p. 21–37.
   Google Scholar
• Wu HX, Li LX, Shen JZ, Wang Y, Liu KL, Zhang SX. 2012. In vitro metabolism of cyadox in rat, chicken and swine using ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry. J Pharmaceut Biomed Anal. 67-68:175–185.
   PubMed Web of Science ®Google Scholar
• Xu N, Huang LL, Liu ZY, Pan YH, Wang X, Tao YF, Chen DM, Wang YL, Peng DP, Yuan ZH. 2011. Metabolism of cyadox by the intestinal mucosa microsomes and gut flora of swine, and identification of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 25:2333–2344.
   PubMed Web of Science ®Google Scholar
• Yang B, Huang LL, Fang K, Wang YL, Peng DP, Liu ZL, Yuan ZH. 2014. A physiologically based pharmacokinetic model for the prediction of the depletion of methyl-3-quinoxaline-2-carboxylic acid, the marker residue of olaquindox, in the edible tissues of pigs. J Vet Pharmacol Ther. 37:66–82.
   PubMed Web of Science ®Google Scholar
• Yang B, Huang LL, Wang YL, Liu Y, Tao YF, Chen DM, Liu ZL, Fang K, Chen YP, Yuan ZH. 2010. Residue depletion and tissue-plasma correlation of methyl-3-quinoxaline-2-carboxylic acid after dietary administration of olaquindox in pigs. J Agric Food Chem. 58:937–942.
   PubMed Web of Science ®Google Scholar
• Yang F, Sun N, Liu YM, Zeng ZL. 2014. Estimating danofloxacin withdrawal time in broiler chickens based on physiologically based pharmacokinetics modeling. J Vet Pharmacol Ther. 37:579–588. [Epub ahead of print].
   Web of Science ®Google Scholar
• Yang X, Zhou Y-F, Yu Y, Zhao D-H, Shi W, Fang B-H, Liu Y-H. 2015. A physiologically based pharmacokinetic model for quinoxaline-2-carboxylic acid in rats, extrapolation to pigs. J Vet Pharmacol Ther. 38:55–64.
   PubMed Web of Science ®Google Scholar
• Zhang HH, Wang X, Huang LL, Pan YH, Li J, Chen DM, Cheng GY, Hao HH, Tao YF, Liu ZL, Yuan ZH. 2015. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1,4-dioxides. Chem Res Toxicol. 28:470–481.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Huang LL, Chen DM, Fan SX, Wang YL, Tao YF, Yuan ZH. 2005. Development of HPLC methods for determination of cyadox and its main metabolites in goat tissues. Analyt Sci. 21:1495–1499.
   PubMed Web of Science ®Google Scholar
• Zhao N, Wang L, Lu -X-X, Jia H-Q, Fang B-H, Zeng Z-L, Ding H-Z. 2013. Pharmacokinetics of cyadox and its major metabolites in swine after intravenous and oral administration. J Integ Agric. 12:495–501.
   Web of Science ®Google Scholar
• Zheng M, Jiang J, Wang J, Tang X, Ouyang M, Deng Y. 2011. The mechanism of enzymatic and non-enzymatic N-oxide reductive metabolism of cyadox in pig liver. Xenobiotica. 41:964–971.
   PubMed Web of Science ®Google Scholar